10:25–10:50

Abstract 7501

A randomized double blind phase 3 trial of   adjuvant erlotinib (E) versus placebo (P) following complete tumor resection   with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA   EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results.  

IHC/FISH检测EGFR阳性的   IB-IIIA期非小细胞肺癌（NSCLC）患者完整切除术后按期别给予或不给予辅助化疗后，埃罗替尼（E）治疗对比安慰剂（P）的随机、双盲、III期研究：RADIANT结果。

刘晓晴(Xiaoqing Liu)

Abstract 7502

Randomized trial on thoracic radiotherapy   (TRT) in extensive-stage small cell lung cancer.

广泛期小细胞肺癌胸部放疗的随机研究。

Abstract 7503

Prophylactic cranial irradiation (PCI) has   a detrimental effect on the overall survival (OS) of patients (pts) with   extensive disease small cell lung cancer (ED-SCLC): Results of a Japanese   randomized phase III trial.

接受预防性脑照射（PCI）对广泛期小细胞肺癌的患者总体生存有害：一项日本随机III期研究的结果。

10:50–11:05

专家评述

Discussion Topic: State of art management of extensive stage SCLC

讨论主题：广泛期小细胞肺癌治疗最新进展

Heather   Wakelee

翻译：杨衿记(Jin-Ji Yang)

11:05–11:10

讨论(Q &   A)

王绿化(Lv-Hua Wang)

卢  铀(You Lu)

Heather   Wakelee